Five health apps reimbursed for remote monitoring in oncology since April 2026 in Belgium

In Belgium, the reimbursement framework for health apps (applications mobiles médicales) is overseen by the National Institute for Health and Disability Insurance (INAMI/RIZIV). The supporting administrative framework, managed by industry associations beMedTech and Agoria, is the mHealthBelgium validation pyramid, which consists of three levels:

• Level 1 – the app is a CE-certified medical device;
• Level 2 – additional ICT criteria fulfilled, and reimbursement application is submitted to INAMI/RIZIV;
• Level 3 – reimbursement within a specific care pathway is approved by INAMI/RIZIV. This level is subdivided into two sub-levels: Level 3- ("light"): the app has not yet demonstrated sufficient socio-economic benefits and is still generating additional evidence; reimbursement is temporary; Level 3+ ("plus"): the app has demonstrated sufficient socio-economic benefits and can be reimbursed on a permanent basis.

In April 2026, five health apps were added to Level 3+ of the mHealthBelgium validation pyramid, meaning regular reimbursement, within the specific care pathway “Remote monitoring of oncology patients”: 

• moveUP (by moveUP);
• Noona (by Varian);
• Malea (by Medtronic);
• RemeCare (by Remecare BV);
• Resilience PRO (by Resilience).

The reimbursement conditions are defined in the National agreement concluded between hospitals and insurance organizations (Convention entre les établissements hospitaliers et les organismes assureurs, 2019, last updated on December 2, 2025). Two packages (lump sum reimbursement) were introduced for “Initiation of oncological remote monitoring” and “Oncological remote monitoring”.

The agreement requires that apps include validated patient questionnaires, a clinically robust alert system with graded alerts (including those generated from patient input and free text), and clear notification mechanisms for care teams, including patient identification and graphical symptom tracking. In addition, apps must be accessible across platforms (Android, iOS, and web browsers) to ensure broad patient usability.

See the full details in French here and here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.